Underwriters of upsized follow-on offering of 2,530,000 shares of common stock of SilverBow Resources, Inc. by an affiliate of Strategic Value Partners, LLC, resulting in gross proceeds of approximately $68.1 million.

Underwriters of SilverBow Resources, Inc.'s upsized follow-on offering of 4,000,000 shares of common stock, which includes 2,810,811 shares offered by SilverBow Resources and 1,189,189 shares offered by an affiliate of Strategic Value Partners, LLC, at public offering price of $37.00 per share, resulting in gross proceeds to SilverBow Resources of approximately $104 million and to the affiliate of Strategic Value Partners of approximately $44 million.

Underwriters in connection with CSX Corporation's public offering of $600 million of its 5.200% Notes due 2033.

Evercore ISI as sales agent in connection with commencement of at-the-market equity offering program by Quantum-Si Incorporated to offer and sell its Class A common stock having aggregate offering price of up to $75 million.

Underwriters of Inozyme Pharma, Inc.'s follow-on offering of 14,375,000 shares of common stock at public offering price of $4.80 per share, resulting in net proceeds to the Company of approximately $64.5 million.

Banco Itaú Chile in connection with tender offer of its common stock and ADS by an affiliate of Itaú Unibanco Holding S.A.

Underwriters in connection with The Interpublic Group of Companies, Inc.'s $300 million offering of Senior Notes.

Underwriters in connection with Bell Canada's registered public offering of $850 million aggregate principal amount of 5.100% Series US-8 Notes due 2033.

Initial purchasers in connection with Rule 144A/Regulation S offering by Dana Financing Luxembourg S.à r.l. of €425 million aggregate principal amount of 8.500% Senior Notes due 2031.

Underwriters of Mineralys Therapeutics, Inc.'s upsized initial public offering of 13,800,000 shares of common stock at public offering price of $16.00 per share, resulting in gross proceeds to the Company of $220.8 million.

Underwriters of Paragon 28, Inc.'s follow-on public offering of 6,500,000 shares of common stock, 3,750,000 shares of which are primary and 2,750,000 shares of which are secondary, at public offering price of $17.00 per share, resulting in gross proceeds to the Company of approximately $59.3 million and to the selling shareholders of approximately $44.1 million.